• Michael A Borger, Fedak Paul W M PWM Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Elizabeth H Stephens, Thomas G Gleason, Evaldas Girdauskas, John S Ikonomidis, Ali Khoynezhad, Samuel C Siu, Subodh Verma, Michael D Hope, Duke E Cameron, Donald F Hammer, Joseph S Coselli, Marc R Moon, Thoralf M Sundt, Alex J Barker, Michael Markl, Alessandro Della Corte, Hector I Michelena, and John A Elefteriades.
• Leipzig Heart Center, Cardiac Surgery, University of Leipzig, Leipzig, Germany. Electronic address: michael.borger@helios-kliniken.de.
• J. Thorac. Cardiovasc. Surg. 2018 Aug 1; 156 (2): e41-e74.

AbstractBicuspid aortic valve disease is the most common congenital cardiac disorder, being present in 1% to 2% of the general population. Associated aortopathy is a common finding in patients with bicuspid aortic valve disease, with thoracic aortic dilation noted in approximately 40% of patients in referral centers. Several previous consensus statements and guidelines have addressed the management of bicuspid aortic valve-associated aortopathy, but none focused entirely on this disease process. The current guidelines cover all major aspects of bicuspid aortic valve aortopathy, including natural history, phenotypic expression, histology and molecular pathomechanisms, imaging, indications for surgery, surveillance, and follow-up, and recommendations for future research. It is intended to provide clinicians with a current and comprehensive review of bicuspid aortic valve aortopathy and to guide the daily management of these complex patients.Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

44 keywords...

hide…